DK101990D0 - 3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese - Google Patents

3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese

Info

Publication number
DK101990D0
DK101990D0 DK101990A DK101990A DK101990D0 DK 101990 D0 DK101990 D0 DK 101990D0 DK 101990 A DK101990 A DK 101990A DK 101990 A DK101990 A DK 101990A DK 101990 D0 DK101990 D0 DK 101990D0
Authority
DK
Denmark
Prior art keywords
aminopropyl
acid
methylphosphic
intermediates
synthesis
Prior art date
Application number
DK101990A
Other languages
English (en)
Other versions
DK101990A (da
Inventor
Judith Mary Hills
William Howson
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK101990A publication Critical patent/DK101990A/da
Publication of DK101990D0 publication Critical patent/DK101990D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK101990A 1988-08-26 1990-04-25 3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese DK101990D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888820266A GB8820266D0 (en) 1988-08-26 1988-08-26 Compounds
PCT/GB1989/000981 WO1990001936A1 (en) 1988-08-26 1989-08-23 3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis

Publications (2)

Publication Number Publication Date
DK101990A DK101990A (da) 1990-04-25
DK101990D0 true DK101990D0 (da) 1990-04-25

Family

ID=10642740

Family Applications (1)

Application Number Title Priority Date Filing Date
DK101990A DK101990D0 (da) 1988-08-26 1990-04-25 3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese

Country Status (13)

Country Link
EP (1) EP0356128B1 (da)
JP (1) JPH03502101A (da)
AT (1) ATE77747T1 (da)
AU (1) AU614668B2 (da)
DE (1) DE68901961T2 (da)
DK (1) DK101990D0 (da)
ES (1) ES2043025T3 (da)
GB (1) GB8820266D0 (da)
GR (1) GR3005094T3 (da)
IE (1) IE892738L (da)
PT (1) PT91525B (da)
WO (1) WO1990001936A1 (da)
ZA (1) ZA896504B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457095A (en) * 1984-10-12 1995-10-10 Ciba-Geigy Corporation Substituted propane-phosponous acid compounds
US5243062A (en) * 1984-10-12 1993-09-07 Ciba-Geigy Corporation Substituted propane-phosphonous acid compounds
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
US5300679A (en) * 1987-12-04 1994-04-05 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
GB8912814D0 (en) * 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
IL98502A (en) * 1990-06-22 1998-04-05 Ciba Geigy Ag History of Aminoalkene Phosphine Acid, Process for Their Preparation and Pharmaceutical Preparations Containing Them
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
GB9308430D0 (en) * 1993-04-23 1993-06-09 Glaxo Group Ltd Medicaments
SE9904507D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
JP2009521430A (ja) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ Ｇａｂａ−ｂ受容体モジュレーター
JP2009521428A (ja) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ 胃腸疾患治療用のイミダゾール誘導体
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
WO2012050907A2 (en) 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
GB8425872D0 (en) * 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
DK101990A (da) 1990-04-25
EP0356128A3 (en) 1990-06-13
EP0356128B1 (en) 1992-07-01
GB8820266D0 (en) 1988-09-28
ATE77747T1 (de) 1992-07-15
PT91525A (pt) 1990-03-08
DE68901961D1 (en) 1992-08-06
IE892738L (en) 1990-02-26
AU614668B2 (en) 1991-09-05
AU4204389A (en) 1990-03-23
PT91525B (pt) 1995-05-04
ES2043025T3 (es) 1993-12-16
JPH03502101A (ja) 1991-05-16
EP0356128A2 (en) 1990-02-28
WO1990001936A1 (en) 1990-03-08
GR3005094T3 (da) 1993-05-24
DE68901961T2 (de) 1992-12-24
ZA896504B (en) 1992-07-29

Similar Documents

Publication Publication Date Title
DK101990A (da) 3-(aminopropyl)-methylphosphinsyre som terapeutisk middel og mellemprodukter til dens syntese
FI924847A0 (fi) 2-aminometyl-kromaner
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
DE69006052D1 (de) 19-Nor-Vitamin-D-Derivate.
NO20003550L (no) Farmasøytiske sammensetninger og anvendelse herav
NO972910L (no) Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
PT656209E (pt) Derivados de melatonina para uso no tratamento de perturbacoes de dessincronizacao
NO953892L (no) Imidazolokinoksalinon-derivater som EAA-antagonister
SE9702066D0 (sv) A new salt
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
DK1556045T3 (da) 4-aminopiperidinderivater, fremgangsmåder til fremstilling deraf og anvendelse deraf som medikamenter
ITMI911578A1 (it) Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
NO893757D0 (no) Anvendelse av basiske nitro-fenyl-dihydropyridinamider som legemidler, nye forbindelser og fremgangsmaater til deresfremstilling via nye mellomprodukter.
ATE74505T1 (de) Schmerzpraeparat.
DK0429324T3 (da) Anvendelse af N-methyl-2-(3pyridyl)-tetrahydrothiopyran-2-carbothioamid-1-oxid til fremstilling af lægemidler beregnet til behandling af coronarinsufficiens
DK236489A (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment